Clinical trials
Completed Phase 3 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26,221 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 355 |
| 2001 | 485 |
| 2002 | 697 |
| 2003 | 903 |
| 2004 | 1,181 |
| 2005 | 1,256 |
| 2006 | 1,406 |
| 2007 | 1,321 |
| 2008 | 1,372 |
| 2009 | 1,244 |
| 2010 | 1,260 |
| 2011 | 1,327 |
| 2012 | 1,293 |
| 2013 | 1,213 |
| 2014 | 1,152 |
| 2015 | 1,157 |
| 2016 | 1,032 |
| 2017 | 953 |
| 2018 | 942 |
| 2019 | 847 |
| 2020 | 870 |
| 2021 | 795 |
| 2022 | 637 |
| 2023 | 526 |
| 2024 | 371 |
| 2025 | 146 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26,221 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 775 |
| AstraZeneca | 569 |
| Merck Sharp & Dohme LLC | 529 |
| Novartis Pharmaceuticals | 522 |
| Pfizer | 439 |
| Sanofi | 437 |
| Eli Lilly and Company | 413 |
| Hoffmann-La Roche | 411 |
| Boehringer Ingelheim | 340 |
| Novo Nordisk A/S | 295 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 1,013 |
| Breast Neoplasms | 596 |
| Diabetes Mellitus | 530 |
| Pain | 480 |
| Hypertension | 478 |
| Asthma | 441 |
| HIV Infections | 437 |
| Pulmonary Disease, Chronic Obstructive | 386 |
| Arthritis, Rheumatoid | 337 |
| Influenza, Human | 324 |
Trials
Showing 1 to 25 of 26,221. Each trial links to its page on Pharma Observatory.
26,121 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.